Offers 27.50 us/share (Il Sole 24 Ore Radiocor) - New York, 18 Jun - The US producer of medical devices Boston Scientific Corporation said it has entered into a definitive agreement to acquire Silk Road Medical, a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization.

The purchase price is 27.50 dollars per share, reflecting an enterprise value of approximately 1.16 billion dollars.

Boston Scientific expects to complete the transaction in the second half of 2024.

Silk Road Medical has guided to net revenue of approximately 194-198 million dollars in 2024, representing 10-12% growth over the prior fiscal year.

"The impact to Boston Scientific adjusted earnings per share is expected to be immaterial in 2024 and 2025, and accretive thereafter," it added.

AAA-Web

(RADIOCOR) 18-06-24 19:01:38 (0660) 5 NNNN